Becker's Healthcare May 7, 2024
Riz Hatton

Life sciences company Geneoscopy received FDA approval for its noninvasive colorectal cancer screening test, ColoSense.

ColoSense is the first noninvasive colorectal cancer screening test to offer a view of disease activity through RNA biomarkers, according...

Today's Sponsors

Venturous
Got healthcare questions? Just ask Transcarent

Today's Sponsor

Venturous

 
Topics: Biotechnology, FDA, Govt Agencies, Patient / Consumer, Pharma / Biotech, Provider
Sun Pharma buys Checkpoint and its new cancer drug
3 ways to accelerate development and de-risk cell and gene therapy manufacturing
FDA OKs First Gene Therapy Implant for a Rare Eye Disease
Anna Greka: Molecular Sleuthing for Rare Diseases
Gene Therapy in an Implant: Neurotech Lands First FDA Approval in Rare Vision Disorder

Share This Article